Abstract
In the PREVENT trial, 143 adult patients with aquaporin-4 (AQP4) immunoglobin G (IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD) were
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have